Stockreport

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF The FDA granted accelerated approval to Krazati, in combination with Erbitux (cetuximab), as a targeted treatment option for adult patients with KRASG12C-mutated locall [Read more]